Intermezzo Coffeehouse by Monika’s Delites
featuring specialty coffees and espresso drinks,
homemade desserts, soups, sandwiches and salads.
12 Park Place, Fredonia, NY 14063
The death toll in Haiti is currently estimated at between 500 to 1,300 people following the October 4th landfall of Hurricane Matthew — the most severe to affect the region in…
An avalanche of refined ideas continues to tumble down from the high-altitude Utah state capital Salt Lake City, where coffee tool and accessory-maker Saint Anthony Industries keeps the wheels of…
The Long Island City, N.Y. multi-service coffee company White Coffee is for the first time getting into the cold brew game, introducing a cold brew system this fall that minimizes brew time…
It was roughly 10 months ago that Lyn Weber Workshops, the makers of the HG One manual grinder, unveiled the EG-1, an innovative and robustly engineered grinder designed specifically for single-dose…
Chicago’s Metric Coffee is opening its first brick-and-mortar café attached to its Near West Chicago roastery. The bar at Metric West Fulton, located at 2021 W. Fulton, sits a short distance from a…
Coffee consumption has been associated with several benefits toward human health. However, its association with mortality risk has yielded contrasting results, including a non-linear relation to all-cause and cardiovascular disease (CVD) mortality and no association with cancer mortality. As smoking habits may affect the association between coffee and health outcomes, the aim of the present study was to update the latest dose-response meta-analysis of prospective cohort studies on the association between coffee consumption and mortality risk and conduct stratified analyses by smoking status and other potential confounders. A systematic search was conducted in electronic databases to identify relevant studies, risk estimates were retrieved from the studies, and dose-response analysis was modeled by using restricted cubic splines. A total of 31 studies comprising 1610,543 individuals and 183,991 cases of all-cause, 34,574 of CVD, and 40,991 of cancer deaths were selected. Analysis showed decreased all-cause [relative risk (RR) = 0.86, 95 % confidence interval (CI) = 0.82, 0.89)] and CVD mortality risk (RR = 0.85, 95 % CI = 0.77, 0.93) for consumption of up to 4 cups/day of coffee, while higher intakes were associated with no further lower risk. When analyses were restricted only to non-smokers, a linear decreased risk of all-cause (RR = 0.94, 95 % CI = 0.93, 0.96), CVD (RR = 0.94, 95 % CI = 0.91, 0.97), and cancer mortality (RR = 0.98, 95 % CI = 0.96, 1.00) for 1 cup/day increase was found. The search for other potential confounders, including dose-response analyses in subgroups by gender, geographical area, year of publication, and type of coffee, showed no relevant differences between strata. In conclusion, coffee consumption is associated with decreased risk of mortality from all-cause, CVD, and cancer; however, smoking modifies the observed risk when studying the role of coffee on human health.
The post G Grosso et al, 2016. Coffee consumption and risk of all-cause, cardiovascular, and cancer mortality in smokers and non-smokers: a dose-response meta-analysis. European Journal of Epidemiology, published online. appeared first on Coffee and Health.
Previous results from studies on the relationship between coffee/caffeine consumption and risk of urinary incontinence (UI) are inconclusive. We aim to assess this association using a meta-analysis of observational studies.
Pertinent studies were identified by searching electronic database (Embase, PubMed and Web of Science) and carefully reviewing the reference lists of pertinent articles until July 2015. Random-effects models were used to derive the summary ORs and corresponding 95 % CIs.
Seven studies (one case-control, two cohort and four cross-sectional) were included in our meta-analysis. The summary ORs for any versus non-consumption were 0.75 (95 % CI 0.54-1.04) for coffee and 1.29 (95 % CI 0.94-1.76) for caffeine consumption. Compared with individuals who never drink coffee, the pooled OR of UI was 0.99 (95 % CI 0.83-1.18) for regular coffee/caffeine drinkers. Coffee/caffeine consumption was not associated with moderate to severe UI (OR 1.18, 95 % CI 0.88-1.58). In stratified analyses by gender, no significant association was found between UI risk and coffee/caffeine consumption in both men (OR 0.99, 95 % CI 0.42-2.32) and women (OR 0.92, 95 % CI 0.80-1.06). By subtype, the pooled ORs were 1.01 (95 % CI 0.86-1.19) for stress UI, 0.99 (95 % CI 0.84-1.16) for urge UI and 0.93 (95 % CI 0.79-1.10) for mixed UI.
This meta-analysis found no evidence for an association between coffee/caffeine consumption and the risk of UI.
The post S Sun et al, 2016. Coffee and caffeine intake and risk of urinary incontinence: a meta-analysis of observational studies, BMC Urology, published online. appeared first on Coffee and Health.
Sure, roasters may boast of exotic and provocative flavor notes, high-altitude growth or experimental processing methods, but until now they have not been able to boast of blue ribbons. On Friday,…
Seattle-based roaster Anchorhead Coffee opened its flagship brick-and-mortar café last week, marking a great stride in the company’s efforts to grow beyond its bottled RTD cold brew origins. Cofounded by…
Background: Nonhuman studies suggest a protective effect of caffeine on cognition. Although human literature remains less consistent, reviews suggest a possible favorable relationship between caffeine consumption and cognitive impairment or dementia. We investigated the relationship between caffeine intake and incidence of cognitive impairment or probable dementia in women aged 65 and older from the Women’s Health Initiative Memory Study.
Methods: All women with self-reported caffeine consumption at enrollment were included (N = 6,467). In 10 years or less of follow-up with annual assessments of cognitive function, 388 of these women received a diagnosis of probable dementia based on a 4-phase protocol that included central adjudication. We used proportional hazards regression to assess differences in the distributions of times until incidence of probable dementia or composite cognitive impairment among women grouped by baseline level of caffeine intake, adjusting for risk factors (hormone therapy, age, race, education, body mass index, sleep quality, depression, hypertension, prior cardiovascular disease, diabetes, smoking, and alcohol consumption).
Results: Women consuming above median levels (mean intake = 261mg) of caffeine intake for this group were less likely to develop incident dementia (hazard ratio = 0.74, 95% confidence interval [0.56, 0.99], p = .04) or any cognitive impairment (hazard ratio = 0.74, confidence interval [0.60, 0.91], p = .005) compared to those consuming below median amounts (mean intake = 64mg) of caffeine for this group.
Conclusion: Our findings suggest lower odds of probable dementia or cognitive impairment in older women whose caffeine consumption was above median for this group and are consistent with the existing literature showing an inverse association between caffeine intake and age-related cognitive impairment.
The post I Driscoll et al, 2016. Relationship Between Caffeine Intake and Risk for Probable Dementia or Global Cognitive Impairment: The Women’s Health Initiative Memory Study, J Gerontol A Biol Sci, published online. appeared first on Coffee and Health.